Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats

Marcin Adamczak1, Marie-Luise Gross, Jan Krtil

  • 1Department of Internal Medicine, University of Heidelberg, Germany.

Insights

High-dose angiotensin-converting enzyme (ACE) inhibitors partially reverse established kidney damage in rats with reduced renal mass. This study confirms ACE inhibitor treatment can regress glomerular, tubular, and vascular lesions, improving renal health.

Area of Science:

  • Nephrology
  • Pharmacology
  • Renal Physiology

Background:

  • Renin-angiotensin system (RAS) blockade halts renal lesion progression.
  • Established glomerulosclerosis may be reversible with pharmacologic RAS blockade.

Purpose of the Study:

  • Confirm high-dose ACE inhibitors reverse established glomerulosclerosis.
  • Quantify effects on glomerular geometry, podocytes, and renal tissue.

Main Methods:

  • Subtotal surgical renal ablation (SNX) in Sprague Dawley rats.
  • Delayed enalapril treatment (48 mg/kg/day) for 4 weeks.
  • Stereological evaluation of renal morphology at 8 and 12 weeks.

Main Results:

  • SNX rats showed higher blood pressure and albuminuria, reduced by enalapril.
  • Glomerulosclerosis, tubulointerstitial, and vascular damage indices significantly decreased with enalapril.
  • Enalapril treatment reversed glomerular hypertrophy and reduced mesangial/endothelial cell numbers.

Conclusions:

  • High-dose ACE inhibitor treatment promotes regression of preexisting renal lesions.
  • Demonstrates partial reversal of glomerular, tubular, and vascular damage.
  • Confirms ACE inhibitors induce remodeling and reversal of hypertrophy in nephrectomized rats.

Related Concept Videos